Optro recombinant human hemoglobin data

SMTG (Boulder, Colo.) reported results from two early Phase II trials, which tested doses up to 100 grams in patients requiring four units of blood.

In the first study of intraoperative use of Optro, in 23 patients who underwent elective surgery, 16 patients received doses of 25-100g. Control patients received standard transfusion therapy. ...